126 related articles for article (PubMed ID: 35944649)
21. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Hong N; Yoon HG; Seo DH; Park S; Kim SI; Sohn JH; Rhee Y
Eur J Cancer; 2017 Sep; 82():103-114. PubMed ID: 28651157
[TBL] [Abstract][Full Text] [Related]
22. Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha).
Jeong JH; Cho S; Pak YK
Exp Mol Med; 2009 Jun; 41(6):406-16. PubMed ID: 19322023
[TBL] [Abstract][Full Text] [Related]
23. [Effect of RNAi-mediated silencing of SREBP2 gene on inflammatory cytokine-induced cholesterol accumulation in HepG2 cells].
Liao JL; Zhao L; Chen Y; Li Q; Chen YY; Ruan XZ; Chen YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Jul; 20(7):526-31. PubMed ID: 23044239
[TBL] [Abstract][Full Text] [Related]
24. SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.
Singh AB; Kan CF; Dong B; Liu J
J Biol Chem; 2016 Mar; 291(10):5373-84. PubMed ID: 26728456
[TBL] [Abstract][Full Text] [Related]
25. Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter.
Meng Y; Zong L
Cell Mol Biol Lett; 2019; 24():65. PubMed ID: 31827541
[TBL] [Abstract][Full Text] [Related]
26. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor/liver X receptor pathway.
Wu M; Wang J; Zhou W; Wang M; Hu C; Zhou M; Jiao K; Li Z
Chem Biol Interact; 2024 Feb; 389():110865. PubMed ID: 38191086
[TBL] [Abstract][Full Text] [Related]
28. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing
Lebeau PF; Byun JH; Platko K; MacDonald ME; Poon SV; Faiyaz M; Seidah NG; Austin RC
J Biol Chem; 2019 Jun; 294(23):9037-9047. PubMed ID: 31004037
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Hepatology; 2008 Sep; 48(3):770-81. PubMed ID: 18752326
[TBL] [Abstract][Full Text] [Related]
30. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism.
Zeng L; Liao H; Liu Y; Lee TS; Zhu M; Wang X; Stemerman MB; Zhu Y; Shyy JY
J Biol Chem; 2004 Nov; 279(47):48801-7. PubMed ID: 15358760
[TBL] [Abstract][Full Text] [Related]
31. Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.
Lemieux C; Gélinas Y; Lalonde J; Labrie F; Richard D; Deshaies Y
Metabolism; 2006 May; 55(5):605-13. PubMed ID: 16631436
[TBL] [Abstract][Full Text] [Related]
32. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein.
Huang W; Tang L; Cai Y; Zheng Y; Zhang L
Biochem Biophys Res Commun; 2014 Jul; 450(2):1051-7. PubMed ID: 24978313
[TBL] [Abstract][Full Text] [Related]
33. Identification and targeting of selective vulnerability rendered by tamoxifen resistance.
Singh M; Zhou X; Chen X; Santos GS; Peuget S; Cheng Q; Rihani A; Arnér ESJ; Hartman J; Selivanova G
Breast Cancer Res; 2020 Jul; 22(1):80. PubMed ID: 32727562
[TBL] [Abstract][Full Text] [Related]
34. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.
Min HK; Kapoor A; Fuchs M; Mirshahi F; Zhou H; Maher J; Kellum J; Warnick R; Contos MJ; Sanyal AJ
Cell Metab; 2012 May; 15(5):665-74. PubMed ID: 22560219
[TBL] [Abstract][Full Text] [Related]
35. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.
Dong B; Wu M; Li H; Kraemer FB; Adeli K; Seidah NG; Park SW; Liu J
J Lipid Res; 2010 Jun; 51(6):1486-95. PubMed ID: 20048381
[TBL] [Abstract][Full Text] [Related]
36. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
37. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
[TBL] [Abstract][Full Text] [Related]
38. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
39. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
Park WC; Jordan VC
Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
[TBL] [Abstract][Full Text] [Related]
40. The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells.
Xu Y; Hernández-Ledezma JJ; Hutchison SM; Bogan RL
Mol Cell Endocrinol; 2018 Sep; 473():124-135. PubMed ID: 29366778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
